Statement Of Changes In Net Assets

Cyfuse Biomedical K.K. - Filing #7582766

Concept As at
2022-09-30
2022-01-01 to
2022-09-30
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of changes in net assets
Statement of changes in net assets
Net assets
1,761,553,000 JPY
1,064,000 JPY
-922,876,000 JPY
1,900,114,000 JPY
100,000,000 JPY
-922,876,000 JPY
JPY
2,721,927,000 JPY
2,721,927,000 JPY
1,899,050,000 JPY
1,548,394,000 JPY
-1,169,657,000 JPY
1,549,458,000 JPY
1,064,000 JPY
JPY
2,618,052,000 JPY
100,000,000 JPY
2,618,052,000 JPY
-1,169,657,000 JPY
-890,156,000 JPY
JPY
100,000,000 JPY
1,064,000 JPY
1,778,959,000 JPY
2,568,052,000 JPY
-890,156,000 JPY
1,777,895,000 JPY
2,568,052,000 JPY
Changes during period
Profit (loss)
-272,411,000 JPY
142,905,000 JPY
JPY
JPY
JPY
142,905,000 JPY
JPY
142,905,000 JPY
JPY
142,905,000 JPY
JPY
JPY
-329,501,000 JPY
-329,501,000 JPY
-329,501,000 JPY
JPY
JPY
JPY
-329,501,000 JPY
Total changes during period
350,655,000 JPY
JPY
103,875,000 JPY
JPY
246,780,000 JPY
JPY
246,780,000 JPY
103,875,000 JPY
350,655,000 JPY
JPY
JPY
-229,501,000 JPY
-279,501,000 JPY
-279,501,000 JPY
50,000,000 JPY
JPY
50,000,000 JPY
-229,501,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.